Cite
HARVARD Citation
Chen, Y. et al. (2021). Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients. Cancer letters. pp. 78-87. [Online].